GREEN CROSS HOLDINGS CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,950 KRW | +1.09% |
|
-4.58% | -14.68% |
| May. 30 | Green Cross Health Net Profit Falls 19.7% in Fiscal 2024; Dividend Declared | MT |
| May. 16 | Green Cross Holdings Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2022 | 2,080B 1.5B | Sales 2023 | 2,058B 1.49B | Capitalization | 746B 539M |
|---|---|---|---|---|---|
| Net income 2022 | 32.82B 23.7M | Net income 2023 | -54.14B -39.09M | EV / Sales 2022 | 0.79 x |
| Net Debt 2022 | 858B 619M | Net Debt 2023 | 1,084B 783M | EV / Sales 2023 | 0.89 x |
| P/E ratio 2022 |
23.8
x | P/E ratio 2023 |
-13.6
x | Employees | 165 |
| Yield 2022 |
1.76% | Yield 2023 |
1.83% | Free-Float | 44.52% |
More Fundamentals
* Assessed data
More news
More news
| 1 day | +1.09% | ||
| 1 week | -4.58% | ||
| 1 month | -13.08% | ||
| 3 months | -15.45% | ||
| 6 months | -5.42% | ||
| Current year | -14.68% |
1 week
13 770.00
14 700.00
1 month
13 770.0016 150.00
Current year
13 770.0017 990.00
1 year
12 920.0017 990.00
3 years
12 920.0036 550.00
5 years
12 920.0056 300.00
10 years
12 920.0062 000.00
| Managers | Title | Age | Since |
|---|---|---|---|
Yong-Jun Huh
CEO | Chief Executive Officer | 49 | 10-02-28 |
Il-Sup Huh
CEO | Chief Executive Officer | 70 | 91-05-31 |
Yeon-Geun Kim
DFI | Director of Finance/CFO | 51 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Il-Sup Huh
CEO | Chief Executive Officer | 70 | 91-05-31 |
Yong-Tae Park
BRD | Director/Board Member | 74 | 09-02-28 |
Yong-Jun Huh
CEO | Chief Executive Officer | 49 | 10-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 7 M€ | +5.36% | - | |
| 0.00% | 4 M€ | -4.41% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 13,950 | +1.09% | 74,085 |
| 24-05-30 | 13,800 | -3.09% | 63,593 |
| 24-05-29 | 14,240 | -1.52% | 42,761 |
| 24-05-28 | 14,460 | -0.41% | 34,060 |
| 24-05-27 | 14,520 | -0.68% | 29,694 |
End-of-day quote Korea S.E., May 30, 2024
More quotes
Green Cross Holdings Corp is a Korea-based investment holding company principally engaged in the manufacture and distribution of pharmaceuticals. The Companyâs products portfolio consists of prescription drugs, blood derivatives, vaccines, cerebrovascular disease treatment, hunter syndrome drugs, as well as over the counter (OTC) drugs, such as skin disease treatment drugs, allergic cream and others. Its products are used for analgesic, treatment of cerebral thrombosis, hypoalbuminemia, genodermatosis and others, as well as prevention of influenza, prophylaxis of varicella, among others. The Company is also involved in the real estate sales and leasing, as well as construction business.
Sector
Pharmaceuticals
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -14.68% | 460M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B |
- Stock Market
- Equities
- A005250 Stock
